RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation PP Roux, D Shahbazian, H Vu, MK Holz, MS Cohen, J Taunton, ... Journal of Biological Chemistry 282 (19), 14056-14064, 2007 | 876 | 2007 |
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity D Shahbazian, PP Roux, V Mieulet, MS Cohen, B Raught, J Taunton, ... The EMBO journal 25 (12), 2781-2791, 2006 | 682 | 2006 |
Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases B Raught, F Peiretti, AC Gingras, M Livingstone, D Shahbazian, ... The EMBO journal 23 (8), 1761-1769, 2004 | 602 | 2004 |
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity E Azenshtein, G Luboshits, S Shina, E Neumark, D Shahbazian, M Weil, ... Cancer research 62 (4), 1093-1102, 2002 | 478 | 2002 |
mRNA helicases: the tacticians of translational control A Parsyan, Y Svitkin, D Shahbazian, C Gkogkas, P Lasko, WC Merrick, ... Nature reviews Molecular cell biology 12 (4), 235-245, 2011 | 386 | 2011 |
mTOR signaling: implications for cancer and anticancer therapy E Petroulakis, Y Mamane, O Le Bacquer, D Shahbazian, N Sonenberg British journal of cancer 94 (2), 195-199, 2006 | 261 | 2006 |
Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma S Murakami, D Shahbazian, R Surana, W Zhang, H Chen, GT Graham, ... Oncogene 36 (9), 1232-1244, 2017 | 196 | 2017 |
eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways D Shahbazian, A Parsyan, E Petroulakis, JWB Hershey, N Sonenberg Cell cycle 9 (20), 4106-4109, 2010 | 164 | 2010 |
Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B D Shahbazian, A Parsyan, E Petroulakis, I Topisirovic, Y Martineau, ... Molecular and cellular biology, 2010 | 164 | 2010 |
p53-dependent translational control of senescence and transformation via 4E-BPs E Petroulakis, A Parsyan, RJO Dowling, O LeBacquer, Y Martineau, ... Cancer cell 16 (5), 439-446, 2009 | 135 | 2009 |
The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis A Parsyan, D Shahbazian, Y Martineau, E Petroulakis, T Alain, O Larsson, ... Proceedings Of The National Academy Of Sciences 106 (52), 22217-22222, 2009 | 129 | 2009 |
Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone … D Bonfil, D Chuderland, S Kraus, D Shahbazian, I Friedberg, R Seger, ... Endocrinology 145 (5), 2228-2244, 2004 | 107 | 2004 |
MEK targeting in N-RAS mutated metastatic melanoma J Thumar, D Shahbazian, SA Aziz, LB Jilaveanu, HM Kluger Molecular cancer 13, 1-10, 2014 | 78 | 2014 |
Identification of novel radiosensitizers in a high-throughput, cell-based screen for DSB repair inhibitors AG Goglia, R Delsite, AN Luz, D Shahbazian, AF Salem, RK Sundaram, ... Molecular cancer therapeutics 14 (2), 326-342, 2015 | 47 | 2015 |
Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase Y Martineau, X Wang, T Alain, E Petroulakis, D Shahbazian, B Fabre, ... Molecular and Cellular Biology, 2014 | 44 | 2014 |
mTOR signaling: implications for cancer and anticancer therapy. E Petroulakis, Y Mamane, O Le Bacquer, D Shahbazian, N Sonenberg British journal of cancer 96, R11-5, 2007 | 41 | 2007 |
Vertical pathway targeting in cancer therapy D Shahbazian, J Sznol, HM Kluger Advances in pharmacology 65, 1-26, 2012 | 23 | 2012 |
Radiation sensitivity and sensitization in melanoma D Shahbazian, RS Bindra, HM Kluger, PM Glazer Pigment cell & melanoma research 26 (6), 2013 | 10 | 2013 |
RNA helicases and their cofactors D Shahbazian, J Pelletier, Y Svitkin, JWB Hershey, A Parsyan Translation and Its Regulation in Cancer Biology and Medicine, 115-134, 2014 | 1 | 2014 |
Cell Biology and Signaling PM Long, UV Wesley, D Jaworski NEURO-ONCOLOGY 12, 7-7, 2010 | 1 | 2010 |